Skip to content

AtriClip® LAA Exclusion System PRO235Recalls & reported problems

Atricure, Inc. · AtriClip® PRO2 Gilinov-Cosgrove LAA Exclusion System 35 · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10840143900174), received between Jul 28, 2022 and Jul 28, 2022 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Appropriate Device Problem Term/Code Not Available1

Patient problems

  • Hemorrhage/Blood Loss/Bleeding1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 28, 2022Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available

    ON (B)(6) 2022 A PATIENT UNDERWENT A MINIMALLY INVASIVE EPICARDIAL SURGICAL LEFT VENTRICULAR LEAD PLACEMENT WITH CONCOMITANT LEFT ATRIAL APPENDAGE (LAA) EXCLUSION. THE PRO235 ATRICLIP WAS PLACED AND THE DISTAL TIP OF THE LEFT ATRIAL APPENDAGE (LAA) WAS EXCISED. AFTER EXCISION OF THE TIP OF THE LAA, PULSATILE BLEEDING WAS OBSERVED. A 45MM ENDO STAPLER WAS THEN USED TO CLOSE THE LAA. BLEEDING WAS STOPPED AND PATIENT LEFT THE OPERATING ROOM IN STABLE CONDITION. THIS WAS A PROCEDURAL COMPLICATION AND THERE WAS NO REPORTED DEVICE MALFUNCTION.

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 15122247 ↗

Other Clip, Implantable devices

All Clip, Implantable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page